NUEVOCOR
Who is NUEVOCOR?
Nuevocor is a biotech start-up in Singapore focused on developing gene therapies for genetic cardiomyopathies by leveraging advanced cell biology and cutting-edge technology platforms, including novel gene therapy vectors and proteomics-based target discovery.
Industry & Specialities
Others
Countries of Operation
Singapore
Headquarters:
Singapore
Company Type:
SME
Company size:
11-50 Employees
Year Founded:
2021 (5 years)
Address:
SINGAPORE, SG
Employees by Department
- IT / Product (3)
- Sales (2)
- Operations (1)
- The Rest (15)
- Total (21)
Key Decision Makers
Brian Edmund Burke
Co-Founder
Christian Beck
Vice President, Corporate Development
Himani Kukreti
Project Manager
Jean Ying Ho
Laboratory Operations Manager
Insight
Signals
At a glanceThe company has corporate shareholder(s) or more than 20 individual shareholders
The company has a sophisticated ownership structure and may be part of a large corporate group
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Employees by Seniority
C-level
1employees
Senior
3employees
Non-managers
10employees
Financials
HIGH
spending power
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has NUEVOCOR been operating for?
- What is the funding status of NUEVOCOR?
- Where is NUEVOCOR's headquarter?
- What NUEVOCOR's spending power?
- Does NUEVOCOR have a presence in the domain it operates in?